Hepatitis C virus (HCV) is the major etiologic agent of non-A, non-B (NANB) viral hepatitis, infecting approximately 4 million people in the U.S. HCV is an enveloped RNA virus containing a single positive-stranded RNA genome. The viral protein NS5B is an RNA-dependent RNA polymerase (RdRp) essential for HCV RNA replication and represents a unique target for antiviral intervention. Although NS5B has been studied in vitro and its crystal structure determined, its molecular mechanism in HCV RNA replication in vivo is poorly understood. The recent development of a reverse genetics system for HCV provides the opportunity to perform genetic analysis of NS5B and other nonstructural viral proteins in HCV RNA replication. The overall goal of this research proposal is to determine the molecular basis underlying HCV RNA replication using biochemical and reverse genetic approaches. We have recently demonstrated that NS5B is able to initiate de novo RNA synthesis with purine but not pyrimidine nucleotides. In this study, we will determine the ribonucleoside triphosphate (NTP) binding site(s) of NS5B using chemical cross-linking and peptide sequence analysis. The biological roles of the NTP binding site(s) of NS5B will then be defined through mutagenesis analysis in conjunction with cross-linking analysis and in vitro RdRp assays for initiation and elongation of RNA synthesis. We have developed efficient cell culture systems for HCV replicon replication. The replicon replication systems will be used to determine the effects of mutations in the NTP binding sites on HCV RNA replication in the cell. As purified recombinant NS5B lacks template specificity in vitro, other nonstructural viral and cellular proteins may be required for specificity of HCV RNA replication in vivo. We will dissect the roles of NS5B and other nonstructural viral proteins in the control of HCV RNA replication by mutagenesis analysis coupled with reverse genetics approaches. These initial studies will lead to our long-term goal to understand the roles of the conserved genomic RNA sequences/structures and viral proteins in HCV RNA replication, virion assembly, and molecular pathogenesis. Information gained from these studies will provide not only meaningful insight to the molecular mechanisms of HCV RNA replication, but also novel antiviral targets for development of specific replicase inhibitors to treat HCV infection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA093712-03S1
Application #
7016438
Study Section
Virology Study Section (VR)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2002-07-05
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
3
Fiscal Year
2005
Total Cost
$22,095
Indirect Cost
Name
University of Kentucky
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Yang, Xiao; Haurigot, Virginia; Zhou, Shangzhen et al. (2010) Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster. Hepatology 52:1877-87
Cai, Zhaohui; Cai, Lei; Jiang, Jieyun et al. (2007) Human serum amyloid A protein inhibits hepatitis C virus entry into cells. J Virol 81:6128-33
Keck, Zhen-Yong; Xia, Jinming; Cai, Zhaohui et al. (2007) Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions. J Virol 81:1043-7
Chang, Kyung-Soo; Cai, Zhaohui; Zhang, Chen et al. (2006) Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J Virol 80:7364-74
Chang, Kyung-Soo; Luo, Guangxiang (2006) The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA. Virus Res 115:1-8
Zhang, Chen; Cai, Zhaohui; Kim, Young-Chan et al. (2005) Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. J Virol 79:8687-97
Cai, Zhaohui; Yi, MinKyung; Zhang, Chen et al. (2005) Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase. J Virol 79:11607-17
Cai, Zhaohui; Zhang, Chen; Chang, Kyung-Soo et al. (2005) Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol 79:13963-73
Cai, Zhaohui; Liang, T Jake; Luo, Guangxiang (2004) Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell. J Virol 78:3633-43
El-Hage, Nazira; Luo, Guangxiang (2003) Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J Gen Virol 84:2761-9